i saw this on the announcement today and got interested to learn more, so i am not sure why company has not went to FDA for full approval but instead going through this CPT PLA code route ? any technical reason or the are planning for it in future ?
also, to learn more about PLA code I come across this old article below not sure if things have changed since 2020 from what was written in the article ?
company in the above announcement says that this clears the path for reimbursement but article below say something different ? so bit confused ... how reimbursement works ?
https://www.darkintelligencegroup.com/the-dark-report/laboratory-billing/insurers-are-rejecting-many-pla-maaa-codes/
it would be good if someone give some opinion it?
Ann: CPT PLA reimbursement code approved in US for PromarkerD, page-5
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.0¢ |
Change
-0.005(0.58%) |
Mkt cap ! $111.3M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.5¢ | 83.5¢ | $147.2K | 173.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 18208 | 83.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 12633 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |